Entrada Therapeutics Inc. (TRDA)
13.28
0.10 (0.76%)
At close: Jan 28, 2025, 3:05 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 67.60M | 45.16M | 291.06M | 39.05M | 16.84M |
| Short-Term Investments | 284.37M | 143.56M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 3.95M | n/a | n/a | n/a |
| Other Long-Term Assets | 6.74M | 5.21M | 872.00K | 541.00K | -801.00K |
| Receivables | 5.88M | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 11.92M | 21.16M | 7.64M | 904.00K | 593.00K |
| Total Current Assets | 369.77M | 209.88M | 298.70M | 39.95M | 17.44M |
| Property-Plant & Equipment | 92.68M | 33.02M | 6.26M | 3.04M | 801.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 99.42M | 42.18M | 7.13M | 3.58M | 801.00K |
| Total Assets | 469.19M | 252.06M | 305.83M | 43.53M | 18.24M |
| Account Payables | 3.28M | 5.99M | 706.00K | 1.60M | 710.00K |
| Deferred Revenue | 132.26M | n/a | n/a | n/a | n/a |
| Short-Term Debt | 14.93M | 16.81M | n/a | n/a | n/a |
| Other Current Liabilities | 11.32M | -830.00K | 6.01M | 1.76M | 1.21M |
| Total Current Liabilities | 158.80M | 21.97M | 6.72M | 3.36M | 1.92M |
| Long-Term Debt | 60.32M | 17.53M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | 396.00K | n/a | 31.84M |
| Total Long-Term Liabilities | 68.04M | 17.53M | 396.00K | 81.66M | 31.84M |
| Total Liabilities | 226.83M | 39.50M | 7.12M | 85.02M | 33.76M |
| Total Debt | 68.23M | 25.94M | n/a | n/a | n/a |
| Common Stock | 3.00K | 3.00K | 3.00K | 1K | 1K |
| Retained Earnings | -194.97M | -188.28M | -93.67M | -42.51M | -15.99M |
| Comprehensive Income | 195.00K | -2.06M | -305.83M | -81.66M | -31.82M |
| Shareholders Equity | 242.36M | 212.55M | 298.72M | -41.49M | -15.52M |
| Total Investments | 284.37M | 143.56M | n/a | n/a | n/a |